The tumour microenvironment (TME) is no longer considered a passive backdrop to cancer. It is a dynamic ecosystem that plays a central role in tumour growth, immune suppression, metastasis and treatment resistance.

Whitepaper highlights:

• Understand how the TME drives cancer progression, immune evasion and therapeutic resistance
• Explore emerging strategies that target the TME to improve cancer therapy outcomes
• Discover how proteomic technologies provide complementary insights across molecular, cellular and spatial levels
• Learn how characterising the TME can reveal prognostic biomarkers and mechanisms of treatment response or failure

Brought to you by